On June 10, 2025, Eton Pharmaceuticals, Inc. held its Annual Meeting, where stockholders elected Paul V. Maier as a director for three years and ratified Crowe LLP as the independent auditor for 2025 with 18.89 million votes in favor. This event is significant as it reflects governance decisions.